FDA Class II · Drug · May 13, 2026
NAPROXEN ORAL SUSPENSION recall — Acella Pharmaceuticals, LLC
Chemical contamination; presence of lead and lithium above specification
Official ID D-0523-2026 · Official record ↗
NAPROXEN ORAL SUSPENSION: recall status
⚠ Recall found. NAPROXEN ORAL SUSPENSION is named in 1 official recall in our current data. Details and the official notices are below — act on the remedy in the official notice.
Recalls naming this model
See all Acella Pharmaceuticals recalls →
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & egg products ↗ (not yet aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain CPSC, NHTSA, and FDA data. Sources last checked July 24, 2026 at 1:09 AM UTC.